Literature DB >> 24522991

Oncologic resection achieving r0 margins improves disease-free survival in parathyroid cancer.

K M Schulte1, N Talat, G Galata, J Gilbert, J Miell, L C Hofbauer, A Barthel, S Diaz-Cano, S R Bornstein.   

Abstract

BACKGROUND: Parathyroid cancer has a poor mid-term prognosis, often because of local recurrence, observed in half of all patients. Modern diagnostic workup increasingly enables a preoperative diagnosis of parathyroid cancer. There is limited evidence that more comprehensive oncologic surgery can reduce the risk of local recurrence. This study aims to identify the best specific surgical approach in parathyroid cancer.
METHODS: This observational cohort study comprises 19 consecutive patients who had undergone oncologic or nononcologic resection for parathyroid cancer. Baseline parameters were compared by using univariate analysis; outcomes were assessed by χ (2) testing and Kaplan-Meier statistics.
RESULTS: Fifteen of 19 patients were primarily operated on in our tertiary center between 1996 and 2013, and four were referred for follow-up because of their cancer diagnosis. Patient cohorts defined by histologic R-status were comparable for established risk factors: sex, calcium levels, low-risk/high-risk status, and presence of vascular invasion. Oncologic resections were performed in 13 of 15 patients primarily treated in the center and 0 of 4 treated elsewhere (χ (2) = 5.6; p < 0.01). R0 margins were achieved in 11 of 13 (85 %) undergoing oncologic resection and 1 of 6 (17 %) undergoing local excision (χ (2) = 8.1; p < 0.01). R0 margins and primary oncologic resection were associated with higher disease-free survival rates (χ (2) = 7.9; p = 0.005 and χ (2) = 4.7; p = 0.03, respectively). Revision surgery achieved R0 margins in only 2 of 4 (50 %) of patients.
CONCLUSIONS: In parathyroid cancer, a more comprehensive surgery (primary oncologic resection) provides significantly better outcomes than local excision as a result of reduction of R1 margins and locoregional recurrence.

Entities:  

Mesh:

Year:  2014        PMID: 24522991     DOI: 10.1245/s10434-014-3530-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  16 in total

1.  [Surgical treatment of parathyroid carcinoma : Does the initial en bloc resection improve the prognosis?]

Authors:  S Wächter; K Holzer; J Manoharan; C Brehm; I Mintziras; D K Bartsch; E Maurer
Journal:  Chirurg       Date:  2019-11       Impact factor: 0.955

2.  Mathematical model for preoperative differential diagnosis for the parathyroid neoplasms.

Authors:  Julia A Krupinova; Alina R Elfimova; Olga Yu Rebrova; Iya A Voronkova; Anna K Eremkina; Elena V Kovaleva; Irina S Maganeva; Anna M Gorbacheva; Ekaterina E Bibik; Andrey A Deviatkin; Galina A Melnichenko; Natalia G Mokrysheva
Journal:  J Pathol Inform       Date:  2022-08-27

3.  Is local resection sufficient for parathyroid carcinoma?

Authors:  Salim Ilksen Basceken; Volkan Genc; Siyar Ersoz; Yusuf Sevim; Suleyman Utku Celik; Ilknur Kepenekci Bayram
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

Review 4.  MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

Authors:  Jens Bollerslev; Camilla Schalin-Jäntti; Lars Rejnmark; Heide Siggelkow; Hans Morreau; Rajesh Thakker; Antonio Sitges-Serra; Filomena Cetani; Claudio Marcocci
Journal:  Eur J Endocrinol       Date:  2019-06-01       Impact factor: 6.664

5.  Parathyroid Carcinoma: Analysis of Patient Characteristics and Outcomes in a Retrospective Review of Eight Cases seen in a Single Center.

Authors:  Shamira Shahar; Kim Piow Lim; Masni Mohamad
Journal:  J ASEAN Fed Endocr Soc       Date:  2019-11-09

6.  Case Report and Systematic Review: Sarcomatoid Parathyroid Carcinoma-A Rare, Highly Malignant Subtype.

Authors:  Yongchao Yu; Yue Wang; Qingcheng Wu; Xuzi Zhao; Deshun Liu; Yongfu Zhao; Yuguo Li; Guangzhi Wang; Jingchao Xu; Junzhu Chen; Ning Zhang; Xiaofeng Tian
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-15       Impact factor: 5.555

7.  Giant parathyroid carcinoma: Diagnostic, difficulties and therapeutic strategies: A case report.

Authors:  Laila Bouzayan; Mohamed Yassine Mabrouk; Hassane Ait Ali; Abdelali Guelil; Achraf Miry; Jabi Rachid; Amal Benani; Mohammed Bouziane
Journal:  Ann Med Surg (Lond)       Date:  2021-10-09

8.  Management and Outcome of Parathyroid Carcinoma-Induced Primary Hyperparathyroidism: A Single-Centre Experience.

Authors:  Loredana De Pasquale; Antonio Mario Bulfamante; Giovanni Felisati; Luca Castellani; Giorgio Ghilardi; Alberto Maria Saibene
Journal:  Int J Endocrinol       Date:  2021-10-07       Impact factor: 3.257

9.  Surgical Disparities of Parathyroid Carcinoma: Long-Term Outcomes and Deep Excavation Based on a Large Database.

Authors:  Ling Zhou; Yihui Huang; Wen Zeng; Sichao Chen; Wei Zhou; Min Wang; Wei Wei; Chao Zhang; Jianglong Huang; Zeming Liu; Liang Guo
Journal:  J Oncol       Date:  2021-05-27       Impact factor: 4.375

10.  Serum circulating miRNA-342-3p as a potential diagnostic biomarker in parathyroid carcinomas: A pilot study.

Authors:  Julia Krupinova; Natalya Mokrysheva; Vasiliy Petrov; Ekaterina Pigarova; Anna Eremkina; Ekaterina Dobreva; Alina Ajnetdinova; Galina Melnichenko; Anatoly Tiulpakov
Journal:  Endocrinol Diabetes Metab       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.